Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer (Q36136558)

12 August 2017

Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer (English)

1 reference

12 August 2017

1 reference

1 reference

1 reference

Melcher AA

1

1 reference

12 August 2017

Mort D

series ordinal

2

1 reference

12 August 2017

Maughan TS

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

10

1 reference

12 August 2017

1651-1654

1 reference

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Chemotherapy of carcinoma of the stomach

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074858

Estimates of the worldwide frequency of sixteen major cancers in 1980

2 October 2017

1 reference

12 December 2020

Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new (1987) TNM system

1 reference

12 December 2020

Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus

1 reference

12 December 2020

The natural history and results of surgical therapy for carcinoma of the stomach. An analysis of 250 cases

1 reference

12 December 2020

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.604

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8932350

1 reference